{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:42:15Z","timestamp":1768315335617,"version":"3.49.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2 TR002346"],"award-info":[{"award-number":["KL2 TR002346"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s11910-023-01285-z","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T06:02:21Z","timestamp":1688709741000},"page":"479-488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Measuring Pathology in Patients with Multiple Sclerosis Using Positron Emission Tomography"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5987-8705","authenticated-orcid":false,"given":"Matthew R.","family":"Brier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farris","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"1285_CR1","doi-asserted-by":"publisher","first-page":"a028969","DOI":"10.1101\/cshperspect.a028969","volume":"8","author":"CC Hemond","year":"2018","unstructured":"Hemond CC, Bakshi R. Magnetic resonance imaging in multiple sclerosis. Cold Spring Harb Perspect Med. 2018;8:a028969.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1285_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41582-021-00537-1","volume":"17","author":"B Bodini","year":"2021","unstructured":"Bodini B, Tonietto M, Airas L, Stankoff B. Positron emission tomography in multiple sclerosis \u2014 straight to the target. Nat Rev Neurol. 2021;17:663\u201375.","journal-title":"Nat Rev Neurol"},{"key":"1285_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1212\/WNL.0000000000001587","volume":"85","author":"M Absinta","year":"2015","unstructured":"Absinta M, Vuolo L, Rao A, Nair G, Sati P, Cortese ICM, et al. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. Neurology. 2015;85:18\u201328.","journal-title":"Neurology"},{"key":"1285_CR4","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/ana.25877","volume":"88","author":"P Maggi","year":"2020","unstructured":"Maggi P, Sati P, Nair G, Cortese ICM, Jacobson S, Smith BR, et al. Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3T MRI study. Ann Neurol. 2020;88:1034\u201342.","journal-title":"Ann Neurol"},{"key":"1285_CR5","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/jcbfm.2015.120","volume":"35","author":"M Veronese","year":"2015","unstructured":"Veronese M, Bodini B, Garc\u00eda-Lorenzo D, Battaglini M, Bongarzone S, Comtat C, et al. Quantification of [11C]PIB PET for imaging myelin in the human brain: a test\u2014retest reproducibility study in high-resolution research tomography. J Cereb Blood Flow Metab. 2015;35:1771\u201382.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1285_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","volume":"133","author":"T Kuhlmann","year":"2017","unstructured":"Kuhlmann T, Ludwin S, Prat A, Antel J, Br\u00fcck W, Lassmann H. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol (Berl). 2017;133:13\u201324.","journal-title":"Acta Neuropathol (Berl)"},{"key":"1285_CR7","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1098\/rstb.1999.0508","volume":"3","author":"H Lassmann","year":"1999","unstructured":"Lassmann H. The pathology of multiple sclerosis and its evolution. McDonald WI, editor. Philos Trans R Soc Lond B Biol ScI. 1999;3:1635\u201340.","journal-title":"Philos Trans R Soc Lond B Biol ScI"},{"key":"1285_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41582-019-0240-y","volume":"15","author":"PM Matthews","year":"2019","unstructured":"Matthews PM. Chronic inflammation in multiple sclerosis \u2014 seeing what was always there. Nat Rev Neurol. 2019;15:582\u201393.","journal-title":"Nat Rev Neurol"},{"key":"1285_CR9","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1177\/1352458518814117","volume":"25","author":"C Elliott","year":"2019","unstructured":"Elliott C, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, et al. Slowly expanding\/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions. Mult Scler J. 2019;25:1915\u201325.","journal-title":"Mult Scler J"},{"key":"1285_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/1352458520958589","volume":"28","author":"A Calvi","year":"2022","unstructured":"Calvi A, Haider L, Prados F, Tur C, Chard D, Barkhof F. In vivo imaging of chronic active lesions in multiple sclerosis. Mult Scler J. 2022;28:683\u201390.","journal-title":"Mult Scler J"},{"key":"1285_CR11","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","volume":"76","author":"M Absinta","year":"2019","unstructured":"Absinta M, Sati P, Masuzzo F, Nair G, Sethi V, Kolb H, et al. Association of chronic active multiple sclerosis lesions with disability in vivo. JAMA Neurol. 2019;76:1474\u201383.","journal-title":"JAMA Neurol"},{"key":"1285_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1600-0404.2008.01137.x","volume":"119","author":"A Seewann","year":"2009","unstructured":"Seewann A, Kooi E-J, Roosendaal SD, Barkhof F, Van Der Valk P, Geurts JJG. Translating pathology in multiple sclerosis: the combination of postmortem imaging, histopathology and clinical findings. Acta Neurol Scand. 2009;119:349\u201355.","journal-title":"Acta Neurol Scand"},{"key":"1285_CR13","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/brain\/awg182","volume":"126","author":"F Bagnato","year":"2003","unstructured":"Bagnato F, Jeffries N, Richert ND, Stone RD, Ohayon JM, McFarland HF, et al. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain. 2003;126:1782\u20139.","journal-title":"Brain"},{"key":"1285_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0404.2009.01221.x","volume":"122","author":"MA Sahraian","year":"2010","unstructured":"Sahraian MA, Radue E-W, Haller S, Kappos L. Black holes in multiple sclerosis: definition, evolution, and clinical correlations. Acta Neurol Scand. 2010;122:1\u20138.","journal-title":"Acta Neurol Scand"},{"key":"1285_CR15","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1212\/WNL.47.6.1469","volume":"47","author":"L Truyen","year":"1996","unstructured":"Truyen L, van Waesberghe JHTM, van Walderveen MAA, van Oosten BW, Polman CH, Hommes OR, et al. Accumulation of hypointense lesions (\u201cblack holes\u201d) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology. 1996;47:1469\u201376.","journal-title":"Neurology"},{"key":"1285_CR16","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/brain\/awac436","volume":"146","author":"CWJ Van Der Weijden","year":"2023","unstructured":"Van Der Weijden CWJ, Biondetti E, Gutmann IW, Dijkstra H, McKerchar R, De Paula FD, et al. Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status. Brain. 2023;146:1243\u201366.","journal-title":"Brain"},{"key":"1285_CR17","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/ana.22521","volume":"70","author":"NM Moll","year":"2011","unstructured":"Moll NM, Rietsch AM, Thomas S, Ransohoff AJ, Lee J-C, Fox R, et al. Multiple sclerosis normal-appearing white matter: pathology\u2013imaging correlations. Ann Neurol. 2011;70:764\u201373.","journal-title":"Ann Neurol"},{"key":"1285_CR18","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/acn3.51354","volume":"8","author":"MR Brier","year":"2021","unstructured":"Brier MR, Snyder AZ, Tanenbaum A, Rudick RA, Fisher E, Jones S, et al. Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability. Ann Clin Transl Neurol. 2021;8:1096\u2013109.","journal-title":"Ann Clin Transl Neurol"},{"key":"1285_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/NEN.0b013e31827bced3","volume":"72","author":"C Laule","year":"2013","unstructured":"Laule C, Pavlova V, Leung E, Zhao G, MacKay AL, Kozlowski P, et al. Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration. J Neuropathol Exp Neurol. 2013;72:42\u201352.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1285_CR20","first-page":"1935","volume":"24","author":"Y Ge","year":"2003","unstructured":"Ge Y, Grossman RI, Babb JS, He J, Mannon LJ. Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. AJNR Am J Neuroradiol. 2003;24:1935\u201340.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1285_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1177\/1352458510384008","volume":"17","author":"C Laule","year":"2011","unstructured":"Laule C, Vavasour IM, Leung E, Li DK, Kozlowski P, Traboulsee AL, et al. Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology. Mult Scler J. 2011;17:144\u201350.","journal-title":"Mult Scler J"},{"key":"1285_CR22","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/acn3.51621","volume":"9","author":"B Xiang","year":"2022","unstructured":"Xiang B, Wen J, Schmidt RE, Sukstanskii AL, Mamah D, Yablonskiy DA, et al. Evaluating brain damage in multiple sclerosis with simultaneous multi-angular-relaxometry of tissue. Ann Clin Transl Neurol. 2022;9:1514\u201327.","journal-title":"Ann Clin Transl Neurol"},{"key":"1285_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-0404.2006.00615.x","volume":"113","author":"L B\u00f6","year":"2006","unstructured":"B\u00f6 L, Geurts JJG, M\u00f6rk SJ, van der Valk P. Grey matter pathology in multiple sclerosis. Acta Neurol Scand. 2006;113:48\u201350.","journal-title":"Acta Neurol Scand"},{"key":"1285_CR24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/01.jnen.0000190067.20935.42","volume":"64","author":"M Vercellino","year":"2005","unstructured":"Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P. Grey Matter pathology in multiple sclerosis. J Neuropathol Exp Neurol. 2005;64:1101\u20137.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1285_CR25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrneurol.2010.93","volume":"6","author":"M Calabrese","year":"2010","unstructured":"Calabrese M, Filippi M, Gallo P. Cortical lesions in multiple sclerosis. Nat Rev Neurol. 2010;6:438\u201344.","journal-title":"Nat Rev Neurol"},{"key":"1285_CR26","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1212\/WNL.0b013e3181f5d4da","volume":"75","author":"M Calabrese","year":"2010","unstructured":"Calabrese M, Battaglini M, Giorgio A, Atzori M, Bernardi V, Mattisi I, et al. Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis. Neurology. 2010;75:1234\u201340.","journal-title":"Neurology"},{"key":"1285_CR27","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1093\/brain\/aws246","volume":"135","author":"M Calabrese","year":"2012","unstructured":"Calabrese M, Poretto V, Favaretto A, Alessio S, Bernardi V, Romualdi C, et al. Cortical lesion load associates with progression of disability in multiple sclerosis. Brain. 2012;135:2952\u201361.","journal-title":"Brain"},{"key":"1285_CR28","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/brain\/aww037","volume":"139","author":"ID Kilsdonk","year":"2016","unstructured":"Kilsdonk ID, Jonkman LE, Klaver R, van Veluw SJ, Zwanenburg JJM, Kuijer JPA, et al. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study. Brain. 2016;139:1472\u201381.","journal-title":"Brain"},{"key":"1285_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.msard.2018.09.025","volume":"26","author":"C Wicken","year":"2018","unstructured":"Wicken C, Nguyen J, Karna R, Bhargava P. Leptomeningeal inflammation in multiple sclerosis: Insights from animal and human studies. Mult Scler Relat Disord. 2018;26:173\u201382.","journal-title":"Mult Scler Relat Disord"},{"key":"1285_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/jon.12444","volume":"27","author":"DM Harrison","year":"2017","unstructured":"Harrison DM, Wang KY, Fiol J, Naunton K, Royal W III, Hua J, et al. Leptomeningeal enhancement at 7T in multiple sclerosis: frequency, morphology, and relationship to cortical volume. J Neuroimaging. 2017;27:461\u20138.","journal-title":"J Neuroimaging"},{"key":"1285_CR31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/jamaneurol.2016.4237","volume":"74","author":"J Zurawski","year":"2017","unstructured":"Zurawski J, Lassmann H, Bakshi R. Use of magnetic resonance imaging to visualize leptomeningeal inflammation in patients with multiple sclerosis: a review. JAMA Neurol. 2017;74:100\u20139.","journal-title":"JAMA Neurol"},{"key":"1285_CR32","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Ch\u00e9telat","year":"2020","unstructured":"Ch\u00e9telat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, et al. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. Lancet Neurol. 2020;19:951\u201362.","journal-title":"Lancet Neurol"},{"key":"1285_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nucmedbio.2011.08.005","volume":"39","author":"J Van Der Aart","year":"2012","unstructured":"Van Der Aart J, Hallett WA, Rabiner EA, Passchier J, Comley RA. Radiation dose estimates for carbon-11-labelled PET tracers. Nucl Med Biol. 2012;39:305\u201314.","journal-title":"Nucl Med Biol"},{"key":"1285_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40658-022-00464-0","volume":"9","author":"S Rossano","year":"2022","unstructured":"Rossano S, Toyonaga T, Bini J, Nabulsi N, Ropchan J, Cai Z, et al. Feasibility of imaging synaptic density in the human spinal cord using [11C]UCB-J PET. EJNMMI Phys. 2022;9:32. This study uses a synaptic vesicle-associated tracer to measure synaptic density in the spinal cord. While not an MS study, this study demonstrates that PET in the spinal cord is possible and opens entirely new avenues of investigation to the MS research community.","journal-title":"EJNMMI Phys"},{"key":"1285_CR35","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.1088\/0031-9155\/61\/22\/7975","volume":"61","author":"BA Thomas","year":"2016","unstructured":"Thomas BA, Cuplov V, Bousse A, Mendes A, Thielemans K, Hutton BF, et al. PETPVC: a toolbox for performing partial volume correction techniques in positron emission tomography. Phys Med Biol. 2016;61:7975.","journal-title":"Phys Med Biol"},{"key":"1285_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/jcbfm.1985.24","volume":"5","author":"M Reivich","year":"1985","unstructured":"Reivich M, Alavi A, Wolf A, Fowler J, Russell J, Arnett C, et al. Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J Cereb Blood Flow Metab. 1985;5:179\u201392.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1285_CR37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/RLU.0000000000000427","volume":"39","author":"AM Maffione","year":"2014","unstructured":"Maffione AM, Rampin L, Grassetto G, L\u2019Erario R, Colletti PM, Rubello D. 18F-FDG PET\/CT in tumefactive multiple sclerosis. Clin Nucl Med. 2014;39:750\u20131.","journal-title":"Clin Nucl Med"},{"key":"1285_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/135245859700300102","volume":"3","author":"C Schiepers","year":"1997","unstructured":"Schiepers C, Van Hecke P, Vandenberghe R, Van Oostende S, Dupont P, Demaerel P, et al. Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis. Mult Scler J. 1997;3:8\u201317.","journal-title":"Mult Scler J"},{"key":"1285_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jns.2005.09.017","volume":"245","author":"N Derache","year":"2006","unstructured":"Derache N, Mari\u00e9 R-M, Constans J-M, Defer G-L. Reduced thalamic and cerebellar rest metabolism in relapsing\u2013remitting multiple sclerosis, a positron emission tomography study: correlations to lesion load. J Neurol Sci. 2006;245:103\u20139.","journal-title":"J Neurol Sci"},{"key":"1285_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1212\/WNL.53.1.149","volume":"53","author":"M Blinkenberg","year":"1999","unstructured":"Blinkenberg M, Jensen CV, Holm S, Paulson OB, Sorensen PS. A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS. Neurology. 1999;53:149\u2013149.","journal-title":"Neurology"},{"key":"1285_CR41","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/ane.13012","volume":"138","author":"A Baumgartner","year":"2018","unstructured":"Baumgartner A, Frings L, Schiller F, Stich O, Mix M, Egger K, et al. Regional neuronal activity in patients with relapsing remitting multiple sclerosis. Acta Neurol Scand. 2018;138:466\u201374.","journal-title":"Acta Neurol Scand"},{"key":"1285_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1006\/nimg.1996.0032","volume":"4","author":"E Paulesu","year":"1996","unstructured":"Paulesu E, Perani D, Fazio F, Comi G, Pozzilli C, Martinelli V, et al. Functional basis of memory impairment in multiple sclerosis: a [18F]FDG PET study. Neuroimage. 1996;4:87\u201396.","journal-title":"Neuroimage"},{"key":"1285_CR43","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1212\/WNL.54.3.558","volume":"54","author":"M Blinkenberg","year":"2000","unstructured":"Blinkenberg M, Rune K, Jensen CV, Ravnborg M, Kyllingsbak S, Holm S, et al. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology. 2000;54:558\u2013558.","journal-title":"Neurology"},{"key":"1285_CR44","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1212\/WNL.48.6.1566","volume":"48","author":"U Roelcke","year":"1997","unstructured":"Roelcke U, Kappos L, Lechner-Scott J, Brunnschweiler H, Huber S, Ammann W, et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18 F-fluorodeoxyglucose positron emission tomography study. Neurology. 1997;48:1566\u201371.","journal-title":"Neurology"},{"key":"1285_CR45","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1136\/jnnp.47.11.1182","volume":"47","author":"DJ Brooks","year":"1984","unstructured":"Brooks DJ, Leenders KL, Head G, Marshall J, Legg NJ, Jones T. Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1984;47:1182\u201391.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1285_CR46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF03164835","volume":"12","author":"X Sun","year":"1998","unstructured":"Sun X, Tanaka M, Kondo S, Okamoto K, Hirai S. Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study. Ann Nucl Med. 1998;12:89\u201394.","journal-title":"Ann Nucl Med"},{"key":"1285_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S1474-4422(09)70043-2","volume":"8","author":"BD Trapp","year":"2009","unstructured":"Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 2009;8:280\u201391.","journal-title":"Lancet Neurol"},{"key":"1285_CR48","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrn2797","volume":"11","author":"K-A Nave","year":"2010","unstructured":"Nave K-A. Myelination and the trophic support of long axons. Nat Rev Neurosci. 2010;11:275\u201383.","journal-title":"Nat Rev Neurosci"},{"key":"1285_CR49","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5","volume":"50","author":"E Vowinckel","year":"1997","unstructured":"Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res. 1997;50:345\u201353.","journal-title":"J Neurosci Res"},{"key":"1285_CR50","doi-asserted-by":"publisher","unstructured":"Rissanen E, Tuisku J, Vahlberg T, Sucksdorff M, Paavilainen T, Parkkola R, et al. Microglial activation, white matter tract damage, and disability in MS. Neurol - Neuroimmunol Neuroinflammation [Internet]. 2018 [cited 2023 Apr 10];5. Available from:\u00a0https:\/\/doi.org\/10.1212\/NXI.0000000000000443","DOI":"10.1212\/NXI.0000000000000443"},{"key":"1285_CR51","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1093\/brain\/awaa275","volume":"143","author":"M Sucksdorff","year":"2020","unstructured":"Sucksdorff M, Matilainen M, Tuisku J, Polvinen E, Vuorimaa A, Rokka J, et al. Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis. Brain. 2020;143:3318\u201330.","journal-title":"Brain"},{"key":"1285_CR52","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2967\/jnumed.113.131698","volume":"55","author":"E Rissanen","year":"2014","unstructured":"Rissanen E, Tuisku J, Rokka J, Paavilainen T, Parkkola R, Rinne JO, et al. In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand 11C-PK11195. J Nucl Med. 2014;55:939\u201344.","journal-title":"J Nucl Med"},{"key":"1285_CR53","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/acn3.51431","volume":"8","author":"Y Kang","year":"2021","unstructured":"Kang Y, Pandya S, Zinger N, Michaelson N, Gauthier SA. Longitudinal change in TSPO PET imaging in progressive multiple sclerosis. Ann Clin Transl Neurol. 2021;8:1755\u20139. Microglia number measured by TSPO PET increases over time in patients with progressive MS.","journal-title":"Ann Clin Transl Neurol"},{"key":"1285_CR54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1468-1331.2003.00571.x","volume":"10","author":"JC Debruyne","year":"2003","unstructured":"Debruyne JC, Versijpt J, Van Laere KJ, De Vos F, Keppens J, Strijckmans K, et al. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Eur J Neurol. 2003;10:257\u201364.","journal-title":"Eur J Neurol"},{"key":"1285_CR55","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1191\/1352458505ms1140oa","volume":"11","author":"J Versijpt","year":"2005","unstructured":"Versijpt J, Debruyne JC, Van Laere KJ, De Vos F, Keppens J, Strijckmans K, et al. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study. Mult Scler J. 2005;11:127\u201334.","journal-title":"Mult Scler J"},{"key":"1285_CR56","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.nbd.2014.01.018","volume":"65","author":"P Giannetti","year":"2014","unstructured":"Giannetti P, Politis M, Su P, Turkheimer F, Malik O, Keihaninejad S, et al. Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study. Neurobiol Dis. 2014;65:203\u201310.","journal-title":"Neurobiol Dis"},{"key":"1285_CR57","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/brain\/awu331","volume":"138","author":"P Giannetti","year":"2015","unstructured":"Giannetti P, Politis M, Su P, Turkheimer FE, Malik O, Keihaninejad S, et al. Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome. Brain. 2015;138:110\u20139.","journal-title":"Brain"},{"key":"1285_CR58","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1093\/brain\/123.11.2321","volume":"123","author":"RB Banati","year":"2000","unstructured":"Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 2000;123:2321\u201337.","journal-title":"Brain"},{"key":"1285_CR59","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1212\/NXI.0000000000001182","volume":"9","author":"O Misin","year":"2022","unstructured":"Misin O, Matilainen M, Nylund M, Honkonen E, Rissanen E, Sucksdorff M, et al. Innate immune cell-related pathology in the thalamus signals a risk for disability progression in multiple sclerosis. Neurol Neuroimmunol Neuroinflammation. 2022;9:e1182.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1285_CR60","doi-asserted-by":"publisher","first-page":"e574","DOI":"10.1212\/NXI.0000000000000574","volume":"6","author":"M Sucksdorff","year":"2019","unstructured":"Sucksdorff M, Tuisku J, Matilainen M, Vuorimaa A, Smith S, Keitil\u00e4 J, et al. Natalizumab treatment reduces microglial activation in the white matter of the MS brain. Neurol Neuroimmunol Neuroinflammation. 2019;6:e574.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1285_CR61","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00415-011-6337-x","volume":"259","author":"JN Ratchford","year":"2012","unstructured":"Ratchford JN, Endres CJ, Hammoud DA, Pomper MG, Shiee N, McGready J, et al. Decreased microglial activation in MS patients treated with glatiramer acetate. J Neurol. 2012;259:1199\u2013205.","journal-title":"J Neurol"},{"key":"1285_CR62","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2967\/jnumed.116.183020","volume":"58","author":"M Sucksdorff","year":"2017","unstructured":"Sucksdorff M, Rissanen E, Tuisku J, Nuutinen S, Paavilainen T, Rokka J, et al. Evaluation of the effect of fingolimod treatment on microglial activation using serial PET imaging in multiple sclerosis. J Nucl Med. 2017;58:1646\u201351.","journal-title":"J Nucl Med"},{"key":"1285_CR63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2191-219X-2-15","volume":"2","author":"A Ju\u010daite","year":"2012","unstructured":"Ju\u010daite A, Csel\u00e9nyi Z, Arvidsson A, \u00c5hlberg G, Julin P, Varn\u00e4s K, et al. Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects. EJNMMI Res. 2012;2:15.","journal-title":"EJNMMI Res"},{"key":"1285_CR64","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s11481-010-9243-6","volume":"6","author":"U Oh","year":"2011","unstructured":"Oh U, Fujita M, Ikonomidou VN, Evangelou IE, Matsuura E, Harberts E, et al. Translocator protein PET imaging for glial activation in multiple sclerosis. J Neuroimmune Pharmacol. 2011;6:354\u201361.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1285_CR65","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00259-015-3043-4","volume":"42","author":"E Park","year":"2015","unstructured":"Park E, Gallezot J-D, Delgadillo A, Liu S, Planeta B, Lin S-F, et al. 11C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas. Eur J Nucl Med Mol Imaging. 2015;42:1081\u201392.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1285_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","volume":"32","author":"DR Owen","year":"2012","unstructured":"Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 2012;32:1\u20135.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1285_CR67","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/ana.24791","volume":"80","author":"E Herranz","year":"2016","unstructured":"Herranz E, Giann\u00ec C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, et al. Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann Neurol. 2016;80:776\u201390.","journal-title":"Ann Neurol"},{"key":"1285_CR68","doi-asserted-by":"publisher","unstructured":"Hamzaoui M, Garcia J, Boffa G, Lazzarotto A, Absinta M, Ricigliano VAG, et al. Positron emission tomography with [18F]-DPA-714 unveils a smoldering component in most multiple sclerosis lesions which drives disease progression. Ann Neurol [Internet]. [cited 2023 May 4];n\/a. Available from:\u00a0https:\/\/doi.org\/10.1002\/ana.26657. Demonstrates three phenotypes of microglia number in lesions: decreased, rim of increased microglia, and universally increased microglia. The presence of globally increase microglia number was associated with clinical progression.","DOI":"10.1002\/ana.26657"},{"key":"1285_CR69","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/glia.24052","volume":"69","author":"E Nutma","year":"2021","unstructured":"Nutma E, Gebro E, Marzin MC, van der Valk P, Matthews PM, Owen DR, et al. Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain. Glia. 2021;69:2447\u201358.","journal-title":"Glia"},{"key":"1285_CR70","doi-asserted-by":"publisher","unstructured":"Owen DRJ, Narayan N, Wells L, Healy L, Smyth E, Rabiner EA, et al. Pro-inflammatory activation of primary microglia and macrophages increases 18kDa translocator protein (TSPO) expression in rodents but not humans. 2690 [Internet]. 2017 [cited 2023 Apr 10]; Available from:\u00a0https:\/\/doi.org\/10.1177\/0271678X17710182","DOI":"10.1177\/0271678X17710182"},{"key":"1285_CR71","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1093\/brain\/awz287","volume":"142","author":"E Nutma","year":"2019","unstructured":"Nutma E, Stephenson JA, Gorter RP, de Bruin J, Boucherie DM, Donat CK, et al. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis. Brain. 2019;142:3440\u201355.","journal-title":"Brain"},{"key":"1285_CR72","doi-asserted-by":"publisher","unstructured":"Ponath G, Park C, Pitt D. The role of astrocytes in multiple sclerosis. Front Immunol [Internet]. 2018 [cited 2023 Apr 26];9. Available from:\u00a0https:\/\/doi.org\/10.3389\/fimmu.2018.00217","DOI":"10.3389\/fimmu.2018.00217"},{"key":"1285_CR73","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1601277","volume":"376","author":"SL Hauser","year":"2017","unstructured":"Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung H-P, Hemmer B, et al. Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis. N Engl J Med. 2017;376:221\u201334.","journal-title":"N Engl J Med"},{"key":"1285_CR74","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa1917246","volume":"383","author":"SL Hauser","year":"2020","unstructured":"Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, et al. Ofatumumab versus teriflunomide in multiple sclerosis. N Engl J Med. 2020;383:546\u201357.","journal-title":"N Engl J Med"},{"key":"1285_CR75","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.2967\/jnumed.117.189597","volume":"58","author":"ML James","year":"2017","unstructured":"James ML, Hoehne A, Mayer AT, Lechtenberg K, Moreno M, Gowrishankar G, et al. Imaging B cells in a mouse model of multiple sclerosis using 64Cu-rituximab PET. J Nucl Med. 2017;58:1845\u201351.","journal-title":"J Nucl Med"},{"key":"1285_CR76","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2967\/jnumed.120.259325","volume":"63","author":"C Guglielmetti","year":"2022","unstructured":"Guglielmetti C, Levi J, Huynh TL, Tiret B, Blecha J, Tang R, et al. Longitudinal imaging of T cells and inflammatory demyelination in a preclinical model of multiple sclerosis using 18F-FAraG PET and MRI. J Nucl Med. 2022;63:140\u20136.","journal-title":"J Nucl Med"},{"key":"1285_CR77","first-page":"1775","volume":"63","author":"MR Brier","year":"2022","unstructured":"Brier MR, Hamdi M, Rajamanikam J, Zhao H, Mansor S, Jones LA, et al. Phase 1 evaluation of 11C-CS1P1 to assess safety and dosimetry in human participants. J Nucl Med Off Publ Soc Nucl Med. 2022;63:1775\u201382.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"1285_CR78","doi-asserted-by":"crossref","unstructured":"Kato H, Okuno T, Isohashi K, Koda T, Shimizu M, Mochizuki H, et al. Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET. J Cereb Blood Flow Metab. 2021;41:369\u201379. Activated astrocytes are a known component of MS pathology and this paper demonstrates that acetate imaging is able to measure that activation. Increase astrocyte activation correlated with pathology measured with diffusion imaging.","DOI":"10.1177\/0271678X20911469"},{"key":"1285_CR79","doi-asserted-by":"publisher","first-page":"e111598","DOI":"10.1371\/journal.pone.0111598","volume":"9","author":"K Takata","year":"2014","unstructured":"Takata K, Kato H, Shimosegawa E, Okuno T, Koda T, Sugimoto T, et al. 11C-Acetate PET imaging in patients with multiple sclerosis. PLoS ONE. 2014;9:e111598.","journal-title":"PLoS ONE"},{"key":"1285_CR80","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1369\/jhc.5A6901.2006","volume":"54","author":"C Wu","year":"2006","unstructured":"Wu C, Tian D, Feng Y, Polak P, Wei J, Sharp A, et al. A novel fluorescent probe that is brain permeable and selectively binds to myelin. J Histochem Cytochem. 2006;54:997\u20131004.","journal-title":"J Histochem Cytochem"},{"key":"1285_CR81","doi-asserted-by":"publisher","first-page":"9304","DOI":"10.1073\/pnas.0600769103","volume":"103","author":"B Stankoff","year":"2006","unstructured":"Stankoff B, Wang Y, Bottlaender M, Aigrot M-S, Dolle F, Wu C, et al. Imaging of CNS myelin by positron-emission tomography. Proc Natl Acad Sci. 2006;103:9304\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"1285_CR82","doi-asserted-by":"publisher","first-page":"14663","DOI":"10.1523\/JNEUROSCI.4082-08.2009","volume":"29","author":"Y Wang","year":"2009","unstructured":"Wang Y, Wu C, Caprariello AV, Somoza E, Zhu W, Wang C, et al. In vivo quantification of myelin changes in the vertebrate nervous system. J Neurosci. 2009;29:14663\u20139.","journal-title":"J Neurosci"},{"key":"1285_CR83","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00259-013-2682-6","volume":"41","author":"FD de Paula","year":"2014","unstructured":"de Paula FD, Copray S, Sijbesma JWA, Willemsen ATM, Buchpiguel CA, Dierckx RAJO, et al. PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB. Eur J Nucl Med Mol Imaging. 2014;41:995\u20131003.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1285_CR84","doi-asserted-by":"publisher","first-page":"8592","DOI":"10.1016\/j.bmc.2010.10.018","volume":"18","author":"C Wu","year":"2010","unstructured":"Wu C, Wang C, Popescu DC, Zhu W, Somoza EA, Zhu J, et al. A novel PET marker for in vivo quantification of myelination. Bioorg Med Chem. 2010;18:8592\u20139.","journal-title":"Bioorg Med Chem"},{"key":"1285_CR85","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/ana.23965","volume":"74","author":"C Wu","year":"2013","unstructured":"Wu C, Zhu J, Baeslack J, Zaremba A, Hecker J, Kraso J, et al. Longitudinal positron emission tomography imaging for monitoring myelin repair in the spinal cord. Ann Neurol. 2013;74:688\u201398.","journal-title":"Ann Neurol"},{"key":"1285_CR86","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1007\/s00259-022-05770-4","volume":"49","author":"CWJ van der Weijden","year":"2022","unstructured":"van der Weijden CWJ, Meilof JF, van der Hoorn A, Zhu J, Wu C, Wang Y, et al. Quantitative assessment of myelin density using [11C]MeDAS PET in patients with multiple sclerosis: a first-in-human study. Eur J Nucl Med Mol Imaging. 2022;49:3492\u2013507.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1285_CR87","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2967\/jnumed.108.057984","volume":"50","author":"MT Fodero-Tavoletti","year":"2009","unstructured":"Fodero-Tavoletti MT, Rowe CC, McLean CA, Leone L, Li Q-X, Masters CL, et al. Characterization of PiB binding to white matter in Alzheimer Disease and other dementias. J Nucl Med. 2009;50:198\u2013204.","journal-title":"J Nucl Med"},{"key":"1285_CR88","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/ana.22320","volume":"69","author":"B Stankoff","year":"2011","unstructured":"Stankoff B, Freeman L, Aigrot M-S, Chardain A, Doll\u00e9 F, Williams A, et al. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4\u2032-methylaminophenyl)- 6-hydroxybenzothiazole. Ann Neurol. 2011;69:673\u201380.","journal-title":"Ann Neurol"},{"key":"1285_CR89","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.msard.2019.07.020","volume":"35","author":"RHF Carvalho","year":"2019","unstructured":"Carvalho RHF, Real CC, Cinini S, Garcez AT, Duran FLS, Marques FLN, et al. [11C]PIB PET imaging can detect white and grey matter demyelination in a non-human primate model of progressive multiple sclerosis. Mult Scler Relat Disord. 2019;35:108\u201315.","journal-title":"Mult Scler Relat Disord"},{"key":"1285_CR90","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.24620","volume":"79","author":"B Bodini","year":"2016","unstructured":"Bodini B, Veronese M, Garc\u00eda-Lorenzo D, Battaglini M, Poirion E, Chardain A, et al. Dynamic imaging of individual remyelination profiles in multiple sclerosis. Ann Neurol. 2016;79:726\u201338.","journal-title":"Ann Neurol"},{"key":"1285_CR91","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12883-015-0502-2","volume":"15","author":"JA Mat\u00edas-Guiu","year":"2015","unstructured":"Mat\u00edas-Guiu JA, Cabrera-Mart\u00edn MN, Mat\u00edas-Guiu J, Oreja-Guevara C, Riola-Parada C, Moreno-Ramos T, et al. Amyloid PET imaging in multiple sclerosis: an 18F-florbetaben study. BMC Neurol. 2015;15:243.","journal-title":"BMC Neurol"},{"key":"1285_CR92","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41598-017-18747-3","volume":"8","author":"P Brugarolas","year":"2018","unstructured":"Brugarolas P, S\u00e1nchez-Rodr\u00edguez JE, Tsai H-M, Basuli F, Cheng S-H, Zhang X, et al. Development of a PET radioligand for potassium channels to image CNS demyelination. Sci Rep. 2018;8:607.","journal-title":"Sci Rep"},{"key":"1285_CR93","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1177\/0271678X20963404","volume":"41","author":"NJ Guehl","year":"2021","unstructured":"Guehl NJ, Ramos-Torres KM, Linnman C, Moon S-H, Dhaynaut M, Wilks MQ, et al. Evaluation of the potassium channel tracer [18F]3F4AP in rhesus macaques. J Cereb Blood Flow Metab. 2021;41:1721\u201333.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1285_CR94","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3174\/ajnr.A5541","volume":"39","author":"R Zivadinov","year":"2018","unstructured":"Zivadinov R, Ramasamy DP, Hagemeier J, Kolb C, Bergsland N, Schweser F, et al. Evaluation of leptomeningeal contrast enhancement using pre-and postcontrast subtraction 3D-FLAIR imaging in multiple sclerosis. Am J Neuroradiol. 2018;39:642\u20137.","journal-title":"Am J Neuroradiol"},{"key":"1285_CR95","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrneurol.2015.80","volume":"11","author":"H Kearney","year":"2015","unstructured":"Kearney H, Miller DH, Ciccarelli O. Spinal cord MRI in multiple sclerosis\u2014diagnostic, prognostic and clinical value. Nat Rev Neurol. 2015;11:327\u201338.","journal-title":"Nat Rev Neurol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-023-01285-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-023-01285-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-023-01285-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T09:03:08Z","timestamp":1693386188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-023-01285-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":95,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1285"],"URL":"https:\/\/doi.org\/10.1007\/s11910-023-01285-z","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"assertion":[{"value":"28 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MRB has received consulting fees from Genentech, EMD Serono, and Bristol Meyers Squibb and has received research support from the NIH and CMSC. FT has not conflicts to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}]}}